Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
British Journal of Cancer
|
December 17, 2009
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
N Murukesh, C Dive, G C Jayson
British Journal of Cancer
|
November 13, 2008
Antiangiogenic drugs in ovarian cancer
G C Kumaran, G C Jayson, A R Clamp
Journal of Cancer Research and Clinical Oncology
|
January 12, 2001
Metallothionein expression in epithelial ovarian cancer: effect of chemotherapy and prognostic significance
E Wrigley, H W Verspaget, G C Jayson, et al.
British Journal of Cancer
|
November 17, 2001
Heparan sulfate proteoglycans and cancer
F H Blackhall, C L Merry, E J Davies, et al.
British Journal of Cancer
|
August 14, 1998
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer
G C Jayson, M Middleton, S M Lee, et al.
British Journal of Cancer
|
January 11, 2007
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
J P B O'Connor, A Jackson, G J M Parker, et al.
Cancer
|
December 15, 1994
Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant
G C Jayson, A Howell, M Harris, et al.
Cancer Research
|
November 1, 1994
Basic fibroblast growth factor increases the multiplication and migration of a serum-free derivative of CACO-2 but does not affect differentiation
G C Jayson, G S Evans, P W Pemberton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2000
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma
S C White, H Anderson, G C Jayson, et al.
British Journal of Cancer
|
July 17, 1999
An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre
P S Sengupta, G C Jayson, R J Slade, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
British Journal of Cancer
|
December 17, 2009
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
N Murukesh, C Dive, G C Jayson
British Journal of Cancer
|
November 13, 2008
Antiangiogenic drugs in ovarian cancer
G C Kumaran, G C Jayson, A R Clamp
Journal of Cancer Research and Clinical Oncology
|
January 12, 2001
Metallothionein expression in epithelial ovarian cancer: effect of chemotherapy and prognostic significance
E Wrigley, H W Verspaget, G C Jayson, et al.
British Journal of Cancer
|
November 17, 2001
Heparan sulfate proteoglycans and cancer
F H Blackhall, C L Merry, E J Davies, et al.
British Journal of Cancer
|
August 14, 1998
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer
G C Jayson, M Middleton, S M Lee, et al.
British Journal of Cancer
|
January 11, 2007
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
J P B O'Connor, A Jackson, G J M Parker, et al.
Cancer
|
December 15, 1994
Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant
G C Jayson, A Howell, M Harris, et al.
Cancer Research
|
November 1, 1994
Basic fibroblast growth factor increases the multiplication and migration of a serum-free derivative of CACO-2 but does not affect differentiation
G C Jayson, G S Evans, P W Pemberton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2000
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma
S C White, H Anderson, G C Jayson, et al.
British Journal of Cancer
|
July 17, 1999
An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre
P S Sengupta, G C Jayson, R J Slade, et al.
Page
of 7